Center-Authored Papers

Filters: Author is Chan, Jennifer A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DTW, Luu B, Cavalli FMG, Aldape K et al..  2016.  Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(21):2468-77. Abstract
S
Northcott PA, Shih DJH, Peacock J, Garzia L, Morrissy SA, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE et al..  2012.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes.. Nature. 488(7409):49-56. Abstract
P
Yao JC, Guthrie KA, Moran C, Strosberg JR, Kulke MH, Chan JA, LoConte N, McWilliams RR, Wolin EM, Mattar B et al..  2017.  Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2016704072. Abstract
I
Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy SA et al..  2017.  Intertumoral Heterogeneity within Medulloblastoma Subgroups.. Cancer cell. 31(6):737-754.e6. Abstract
E
Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL et al..  2009.  Evaluation of the 8q24 prostate cancer risk locus and MYC expression.. Cancer research. 69(13):5568-74. Abstract
C
Shih DJH, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM et al..  2014.  Cytogenetic Prognostication Within Medulloblastoma Subgroups.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(9):886-96. Abstract